Alpha Tau Medical (DRTS) Other financing activities (2021 - 2022)

Alpha Tau Medical's (DRTS) quarterly Other financing activities came in at $1.5 million in Q2 2022, down 26.19% quarter-over-quarter from $2.0 million in Q1 2022.

Alpha Tau Medical (DRTS) Other financing activities (2021 - 2022) Analysis & Trends

Alpha Tau Medical has disclosed Other financing activities across 2 years of filings, most recently posting $1.5 million for Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Alpha Tau Medical 2,416.70 -76.42 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 1.46 Mn
Jun 30, 2022 1.46 Mn
Mar 31, 2022 1.98 Mn
Mar 31, 2022 1.98 Mn
Mar 31, 2021 145,000.00
Mar 31, 2021 145,000.00